- Home
- CUE vs ABLV Comparison
CUE vs ABLV Comparison
Compare CUE & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- ABLV
- Stock Information
- Founded
- CUE 2014
- ABLV 2015
- Country
- CUE United States
- ABLV China
- Employees
- CUE N/A
- ABLV N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- ABLV
- Sector
- CUE Health Care
- ABLV
- Exchange
- CUE Nasdaq
- ABLV Nasdaq
- Market Cap
- CUE 58.9M
- ABLV 47.3M
- IPO Year
- CUE 2018
- ABLV N/A
- Fundamental
- Price
- CUE $0.65
- ABLV $1.24
- Analyst Decision
- CUE Strong Buy
- ABLV
- Analyst Count
- CUE 3
- ABLV 0
- Target Price
- CUE $3.00
- ABLV N/A
- AVG Volume (30 Days)
- CUE 163.7K
- ABLV 12.2K
- Earning Date
- CUE 05-12-2025
- ABLV 04-23-2025
- Dividend Yield
- CUE N/A
- ABLV N/A
- EPS Growth
- CUE N/A
- ABLV N/A
- EPS
- CUE N/A
- ABLV N/A
- Revenue
- CUE $7,991,000.00
- ABLV $128,932,647.00
- Revenue This Year
- CUE N/A
- ABLV N/A
- Revenue Next Year
- CUE $25.99
- ABLV N/A
- P/E Ratio
- CUE N/A
- ABLV N/A
- Revenue Growth
- CUE 13.83
- ABLV N/A
- 52 Week Low
- CUE $0.45
- ABLV $0.55
- 52 Week High
- CUE $1.99
- ABLV $1.90
- Technical
- Relative Strength Index (RSI)
- CUE 40.82
- ABLV 55.84
- Support Level
- CUE $0.61
- ABLV $1.08
- Resistance Level
- CUE $0.71
- ABLV $1.16
- Average True Range (ATR)
- CUE 0.06
- ABLV 0.10
- MACD
- CUE -0.00
- ABLV -0.01
- Stochastic Oscillator
- CUE 30.70
- ABLV 79.17
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.